Drug Type Small molecule drug |
Synonyms Trimetrexate glucuronate (USAN), NSC-328564, NSC-352122 + [1] |
Target |
Mechanism Bacterial DHFR inhibitors(Bacterial dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (17 Dec 1993), |
Regulation- |
Molecular FormulaC25H33N5O10 |
InChIKeyZCJXQWYMBJYJNB-LRDBBFHQSA-N |
CAS Registry82952-64-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06239 | Trimetrexate Glucuronate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pneumonia, Pneumocystis | US | 17 Dec 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | US | 31 Aug 2001 |